Alberta clinicians describe a fragmented path to iron-deficiency anemia care in reproductive-aged women
Iron-deficiency anemia remains common in reproductive-aged women, yet clinicians in Alberta described a care pathway that is inconsistent, under-resourced, and shaped by inequity at nearly every step. In semistructured interviews conducted from March to June 2024, health care professionals said diagnosis and treatment often depend on where a patient enters the system, which clinician she sees, and how much time the encounter allows for investigation of the underlying cause.
The qualitative study brought together 13 health care professionals, including family physicians, other specialists, and a pharmacist. Their accounts converged on four themes: gaps in physician knowledge, skills, and guideline adherence; system and infrastructure constraints; difficulty delivering patient-centred care; and weak networking within an integrated care system. Each of those themes intersected with health inequity, and the interview data repeatedly returned to the same clinical reality: reproductive-aged women with iron deficiency are still too often treated as if the problem begins and ends with a low hemoglobin value.
One clinician-level concern stood out sharply. Source control was not reliably pursued. When menstrual blood loss, gastrointestinal loss, or another driver of iron depletion is missed, therapy may briefly improve laboratory values while the true cause continues unchecked. In everyday practice, that can translate into repeated relapses, delayed specialty referral, and escalating patient frustration.
Knowledge gaps and inconsistent guideline use shape bedside decisions
Participants described uneven familiarity with IDA guidelines and inconsistent application of existing recommendations. Some clinicians recognized clear diagnostic pathways, while others appeared to rely on fragmented habits formed in busy practice settings. The result was variability in how quickly iron deficiency was identified, how thoroughly it was investigated, and whether treatment moved beyond symptomatic or temporary measures.
Several interviewees pointed to missed opportunities in assessment. The discussion around source control was especially telling because iron deficiency in women of reproductive age is rarely a self-contained lab abnormality; it is usually a signal of blood loss, dietary insufficiency, malabsorption, or a combination of factors. When the underlying driver is not identified, oral or intravenous iron becomes a partial response rather than a durable fix.
A single lab result can hide a longer story of repeated blood loss.
System constraints slow diagnosis, treatment, and referral
System-level barriers were described as persistent and practical. Limited time in primary care visits, constrained access to investigations, and shortages in health human resources made it harder to complete the full workup needed for durable management. Participants also described delays in referral and weak coordination between settings, leaving patients to navigate a patchwork of appointments and recommendations.
The interviews suggested that these obstacles do more than slow care; they shape clinical thinking itself. In a high-volume environment, clinicians may settle for the fastest intervention rather than the most complete one. When that happens, even well-intentioned care can drift toward symptom management instead of cause-directed treatment. The burden is amplified when follow-up depends on patient persistence, transport, schedule flexibility, and the ability to advocate in a system that does not always connect the dots for them.
The infrastructure problem is not abstract. It changes whether a woman gets investigated, treated, and seen again before the cycle repeats.
Sexism, normalization of suffering, and trust affect equity-deserving patients
Equity-deserving groups emerged as a central concern throughout the interviews. Clinicians described how sexism and the normalization of suffering can shape both the presentation of symptoms and the response they receive. When heavy menstrual bleeding, fatigue, dizziness, or reduced functioning are treated as routine rather than clinically meaningful, diagnosis can be delayed and symptoms minimized.
Biopsychosocial factors also complicated access, trust, and adherence. Participants described how poverty, competing life demands, and prior negative experiences with care can make follow-up harder and treatment less likely to succeed. These issues are not peripheral to iron-deficiency anemia; they determine whether a patient can obtain testing, fill a prescription, return for reassessment, or tolerate a treatment plan that may require repeated visits and sustained engagement.
The interviews also showed how clinician communication matters. Patient-centred care was not framed as a vague ideal but as a concrete requirement for treatment acceptance and continuity. In the setting of fatigue, heavy bleeding, and recurring symptoms, patients need explanations that fit their lives, not only their chart values.
Fewer facilitators than barriers point to a narrow improvement path
Investigators identified fewer facilitators than barriers, and that imbalance itself is clinically meaningful. Some clinicians pointed to teamwork, professional networks, and the possibility of better integration across care settings as helpful levers. Even so, the overall message from the interviews was that current supports are not robust enough to offset the depth of the obstacles.
Harmonized guidelines, better education, and more reliable access to human resources emerged as recurring solutions. Participants also emphasized the need to leverage societal assets to address upstream factors such as poverty, since treatment success often depends on resources well outside the clinic room. In practice, the findings suggest that improving IDA care will require more than reminding clinicians to prescribe iron. It will require a coordinated system that can recognize the cause, reduce delay, and keep patients engaged long enough to recover iron stores and prevent recurrence.
The study’s qualitative design is important here. Rather than measuring hemoglobin change or treatment response, it captures the logic of care as clinicians experience it: where the process breaks down, which patients are most affected, and why available tools are not reaching their full potential. Those perspectives matter because they point directly to the points of failure that a future intervention would need to fix.
For reproductive-aged women in Alberta, especially those already carrying the weight of inequity, the interviews depict a system in which IDA is recognized too late, treated too narrowly, and followed too inconsistently. The next step is not another isolated clinical recommendation. It is a coordinated response that links diagnosis, source evaluation, referral, and support across the patient’s entire care pathway.